1,3-dipropyl-8-cyclopentylxanthine has been researched along with fk 352 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanaoka, K; Kadowaki, M; Nagakura, Y; Takeda, M; Tokita, K; Tomoi, M | 1 |
| Hanaoka, K; Kadowaki, M; Nagakura, Y; Tokita, K; Tomoi, M | 1 |
2 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and fk 352
| Article | Year |
|---|---|
Adenosine A1 receptor blockade reverses dysmotility induced by ischemia-reperfusion in rat colon.
Topics: Animals; Colon; Gastrointestinal Motility; Male; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Reperfusion Injury; Xanthines | 2000 |
Adenosine A1 receptor blockade reverses experimental postoperative ileus in rat colon.
Topics: Anesthesia; Animals; Cecostomy; Colon; Dose-Response Relationship, Drug; Gastrectomy; Gastrointestinal Motility; Gastrointestinal Transit; Intestinal Obstruction; Male; Postoperative Complications; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Xanthines | 2003 |